[go: up one dir, main page]

SI1115704T1 - Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse - Google Patents

Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse

Info

Publication number
SI1115704T1
SI1115704T1 SI9930391T SI9930391T SI1115704T1 SI 1115704 T1 SI1115704 T1 SI 1115704T1 SI 9930391 T SI9930391 T SI 9930391T SI 9930391 T SI9930391 T SI 9930391T SI 1115704 T1 SI1115704 T1 SI 1115704T1
Authority
SI
Slovenia
Prior art keywords
cyclin
inhibitory effect
new substituted
cdk complexes
various kinases
Prior art date
Application number
SI9930391T
Other languages
English (en)
Inventor
Rainer Walter
Wolfgang Grell
Armin Heckel
Frank Himmelsbach
Wolfgang Eberlein
Gerald Roth
Meel Jacobus C. A. Van
Norbert Redemann
Walter Spevak
Ulrike Tontsch-Grunt
R�DEN Thomas VON
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19844003A external-priority patent/DE19844003A1/de
Priority claimed from DE19937496A external-priority patent/DE19937496A1/de
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SI1115704T1 publication Critical patent/SI1115704T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9930391T 1998-09-25 1999-09-22 Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse SI1115704T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19844003A DE19844003A1 (de) 1998-09-25 1998-09-25 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19937496A DE19937496A1 (de) 1999-08-07 1999-08-07 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
EP99947404A EP1115704B1 (de) 1998-09-25 1999-09-22 Neue substituierte indolinone mit einer inhibierenden wirkung auf verschiedene kinasen und cyclin/cdk-komplexe
PCT/EP1999/007040 WO2000018734A1 (de) 1998-09-25 1999-09-22 Neue substituierte indolinone mit inhibierender wirkung auf verschiedene kinasen und cyclin/cdk-komplexe

Publications (1)

Publication Number Publication Date
SI1115704T1 true SI1115704T1 (sl) 2003-12-31

Family

ID=26049076

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930391T SI1115704T1 (sl) 1998-09-25 1999-09-22 Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse

Country Status (28)

Country Link
US (1) US6855710B2 (sl)
EP (1) EP1115704B1 (sl)
JP (1) JP2002525356A (sl)
KR (1) KR20010085841A (sl)
CN (1) CN1319090A (sl)
AT (1) ATE243195T1 (sl)
AU (1) AU763361B2 (sl)
BG (1) BG105327A (sl)
BR (1) BR9914065A (sl)
CA (1) CA2342622A1 (sl)
DE (1) DE59906030D1 (sl)
DK (1) DK1115704T3 (sl)
EA (1) EA200100320A1 (sl)
EE (1) EE200100184A (sl)
ES (1) ES2196860T3 (sl)
HR (1) HRP20010216A2 (sl)
HU (1) HUP0104973A3 (sl)
ID (1) ID27757A (sl)
IL (1) IL141622A0 (sl)
NO (1) NO20011477L (sl)
NZ (1) NZ510845A (sl)
PL (1) PL346898A1 (sl)
PT (1) PT1115704E (sl)
SI (1) SI1115704T1 (sl)
SK (1) SK4032001A3 (sl)
TR (1) TR200100854T2 (sl)
WO (1) WO2000018734A1 (sl)
YU (1) YU21301A (sl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6765012B2 (en) * 2001-09-27 2004-07-20 Allergan, Inc. 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
DE60318188T2 (de) 2002-03-26 2008-12-11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
DE10233366A1 (de) * 2002-07-23 2004-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
PE20040701A1 (es) * 2002-07-23 2004-11-30 Boehringer Ingelheim Pharma Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
DE10237423A1 (de) * 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
KR20050036982A (ko) * 2002-08-29 2005-04-20 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 염증, 알러지 및 증식성 질환의 치료에 글루코코르티코이드모사체로 사용하기 위한 3-(설폰아미도에틸)-인돌 유도체
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
US20050043233A1 (en) 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
DE602004017884D1 (de) * 2003-10-03 2009-01-02 Boehringer Ingelheim Pharma Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
JP4861976B2 (ja) 2004-03-11 2012-01-25 アクテリオン ファーマシューティカルズ リミテッド インドール−1−イル酢酸誘導体
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
ES2326907T3 (es) 2004-12-27 2009-10-21 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y su uso.
JP5053997B2 (ja) * 2005-04-28 2012-10-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 炎症性疾患の治療用の新規化合物
BRPI0720131A2 (pt) 2006-12-06 2014-02-04 Boehringer Ingelheim Int Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos.
WO2008073509A2 (en) * 2006-12-11 2008-06-19 Genentech, Inc. Compositions and methods for treating a neoplasm
CN101273991B (zh) * 2007-03-28 2010-05-26 广东同德药业有限公司 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用
PE20091445A1 (es) 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
RU2525114C2 (ru) 2007-12-03 2014-08-10 Бёрингер Ингельхайм Интернациональ Гмбх Способ получения производного индолинона
EP2238108B1 (en) * 2008-01-25 2012-08-29 Boehringer Ingelheim International GmbH Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
KR20110020902A (ko) 2008-06-06 2011-03-03 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 유사체, 이의 제조방법, 약제학적 조성물 및 이의 용도
UY32010A (es) 2008-07-29 2010-02-26 Boehringer Ingelheim Int Nuevas indolinonas, composiciones conteniéndolas y aplicaciones
JPWO2013137371A1 (ja) * 2012-03-15 2015-08-03 興和株式会社 新規ピリミジン化合物及びそれらを含有する医薬
CN103664737A (zh) * 2012-09-25 2014-03-26 杨子娇 一类治疗房角狭窄的化合物及其用途
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. CHROMATOGRAPHY RESIN WITH LIGAND MIXED MODE ANIONIC / HYDROPHOBIC EXCHANGE
CN114957084B (zh) * 2022-01-21 2023-05-09 九江学院 一种吲哚酮类化合物及其制备方法和应用
WO2025155711A1 (en) * 2024-01-17 2025-07-24 The Board Of Trustees Of The Leland Stanford Junior University Lrrk2 inhibitors and compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
US20040058978A1 (en) 2004-03-25
TR200100854T2 (tr) 2001-12-21
NZ510845A (en) 2003-10-31
ID27757A (id) 2001-04-26
PL346898A1 (en) 2002-03-11
EA200100320A1 (ru) 2001-10-22
ATE243195T1 (de) 2003-07-15
KR20010085841A (ko) 2001-09-07
HRP20010216A2 (en) 2002-04-30
SK4032001A3 (en) 2001-11-06
YU21301A (sh) 2003-04-30
AU6086399A (en) 2000-04-17
PT1115704E (pt) 2003-11-28
IL141622A0 (en) 2002-03-10
DE59906030D1 (de) 2003-07-24
HUP0104973A2 (hu) 2002-04-29
NO20011477D0 (no) 2001-03-22
ES2196860T3 (es) 2003-12-16
CN1319090A (zh) 2001-10-24
EP1115704A1 (de) 2001-07-18
BR9914065A (pt) 2001-06-19
NO20011477L (no) 2001-03-22
HUP0104973A3 (en) 2002-06-28
JP2002525356A (ja) 2002-08-13
DK1115704T3 (da) 2003-09-29
AU763361B2 (en) 2003-07-17
EE200100184A (et) 2002-08-15
EP1115704B1 (de) 2003-06-18
CA2342622A1 (en) 2000-04-06
BG105327A (bg) 2001-12-29
US6855710B2 (en) 2005-02-15
WO2000018734A1 (de) 2000-04-06

Similar Documents

Publication Publication Date Title
SI1115704T1 (sl) Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse
DK1071665T3 (da) Substituerede indolinoner med en inhiberende virkning på kinaser og cyclin/CDK-komplekser
DE69909584D1 (de) Schraube mit Vertiefung und Schraubenziehereinsatz hierfür
DE69928608D1 (de) Fräse mit Randfräsmöglichkeit
HU9603142D0 (en) Integrated level two cache and memory controller with multiple data ports
NO20014659L (no) Arylsubstituerte pyrazoler, imidazoler, oksazoler, tiazoler og pyrroler samt deres anvendelse
PT1076558E (pt) 2-fenil-1-¬4-(2-aminoetoxi)-benzil|-indole em combinacao com estrogenios
DE69719348D1 (de) Fräser mit schneideinsatz
DE59801818D1 (de) Steckdübel
PT1157019E (pt) 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2
DE69905364D1 (de) Fräsvorrichtung im bohrloch
NO304984B1 (no) Fosfonometylerte chitosaner samt deres anvendelse for bleking av cellulosematerialer og i kosmetiske sammensetninger
NO990053D0 (no) Fresstyring med orienterings- og dybdebestemmelsesevne
ZA200102260B (en) Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes.
SI1071665T1 (sl) Substituirani indolinoni, ki imajo inhibitorni učinek na kinaze in ciklin/CDK komplekse
GB9809201D0 (en) Microcomputer chips with interconnected address and data paths
NO308528B1 (no) Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene
IL134344A0 (en) Kinase activating dependent cyclin protein kinases, and their uses
FI973293A7 (fi) Sovitelma työkalussa
ITMI980292U1 (it) Oggetto reggi piatto e bicchiere per pasto in piedi
ITMI980880A1 (it) Oggetto reggi piatto e bicchiere per pasto in piedi
KR970004050U (ko) 어학실습실의 헤드폰 보관함
KR980000459U (ko) 좌우선회가능한 파지아암을 구비한 독서대
KR960000284U (ko) 싱크대의 미니선반
BR8802012A (pt) Plano integrado de preparacao de profissionais tecnicos nas areas contabil,juridica e administrativa de empresas em geral